Basel Medical Group Ltd (BMGL) stock
BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30
$0.30−0.17 (-35.68%)
Close on Nov 16, 2026Market cap $478.27KP/E –Yield –
Basel Medical r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Basel Medical
Basel Medical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?